Clinical Trials Browser

Thymoma × regorafenib × Clear all

NCT02307500 2022-09-10

RESOUND

Phase 2 Completed

DermatologicGastrointestinalGynecologicSarcomaThoracic

Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Thymoma